TEVA NEUROSCIENCE, INC.
PARSIPPANY, NJ

TEVA NEUROSCIENCE, INC. is a leading player in the pharmaceutical industry, specializing in both specialty and generic pharmaceuticals. Founded on April 17, 2000, and incorporated as a Florida Model DOS (DOES) company under File Number F00000002113, Teva Neuroscience operates from its mailing address at 400 Interpace Parkway, Parsippany, NJ, 07054. The company has its headquarters designated in DE with Leon County affiliation. As the world's leading generics manufacturer, TEVA NEUROSCIENCE ensures that responsibility is a fundamental aspect of its business operations, reflecting this ethos by making quality healthcare accessible through both innovative therapies and affordable medications. Remarkably, one in every six prescriptions dispensed in the United States involves a Teva product. With an ongoing commitment to addressing customer inquiries related to medical conditions or product effects through consultation with healthcare professionals, TEVA NEUROSCIENCE provides support via its dedicated hotline at 888-TEVA-USA (888-838-2872). The website for further information about their services and offerings is tevaneuroscience.com. The company's leadership includes key officers such as Christine Fox serving as President, Brian Shanahan in the role of Vice-President, and Sharon Barber-Lui as Senior Executive. Notably, TEVA NEUROSCIENCE underwent a name change amendment event on March 14, 2003, demonstrating its dynamic progression through the industry. The organization filed its last annual report for the year 2024 on May 1, 2024. Fei Number associated with their incorporation is 233023331.